| |
|
|
|
|
|
|
|||
|
Blood, Vol. 109, Issue 10, 4158-4163, May 15, 2007
A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome Files in this Data Supplement:
| |||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||